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Moscow State University, Moscow, RussiaABSTRACT Blood coagulation is triggered not only by surface tissue factor (TF) density but also by surface TF distribution. We
investigated recognition of surface TF distribution patterns during blood coagulation and identified the underlying molecular
mechanisms. For these investigations, we employed 1), an in vitro reaction-diffusion experimental model of coagulation;
and 2), numerical simulations using a mathematical model of coagulation in a three-dimensional space. When TF was uniformly
immobilized over the activating surface, the clotting initiation time in normal plasma increased from 4 min to >120 min, with a
decrease in TF density from 100 to 0.7 pmol/m2. In contrast, surface-immobilized fibroblasts initiated clotting within 3–7 min,
independently of fibroblast quantity and despite a change in average surface TF density from 0.5 to 130 pmol/m2. Experiments
using factor V-, VII-, and VIII-deficient plasma and computer simulations demonstrated that different responses to these two TF
distributions are caused by two positive feedback loops in the blood coagulation network: activation of the TF–VII complex by
factor Xa, and activation of factor V by thrombin. This finding suggests a new role for these reactions: to supply sensitivity to local
TF density during blood coagulation.INTRODUCTIONBlood coagulation is activated upon vessel wall injury from
the contact of blood with the transmembrane glycoprotein
tissue factor (TF) that is exposed on almost all extravascular
cells. TF can also be expressed on endothelial or immune
cells during certain pathological processes, such as inflam-
mation (1). This contact leads to the formation of the ex-
trinsic tenase complex between TF and the circulating
activated factor VII (fVIIa), which can activate factor X
(fX) and begin the blood coagulation reaction cascade.
Clotting initiation is tightly regulated by a complex mecha-
nism: fVIIa initially accounts for only 1% of the fVII that is
activated in a feedback loop by the fXa and fIIa produced
during coagulation (2).
Although many well-established in vitro experimental
coagulation models predominantly employ TF homoge-
neously distributed throughout the reaction volume (3,4),
both physiological and pathological coagulation processes
in vivo are likely often activated by TF-expressing cell
layers (5,6). The size of the activating region can vary
greatly, from a single TF-expressing cell to a monolayer
that is several centimeters wide, and the same is true for
TF density within this region. Reported physiological TF
densities range from <1 molecule/mm2 on endothelial cells
in culture (approximated from previous studies (7,8)) to ~5
molecules/mm2 in vivo underneath atherosclerotic plaques
(9,10) and ~100 molecules/mm2 on fibroblasts (7). For in-
vestigations in basic research, pharmacology, diagnostics,Submitted December 19, 2010, and accepted for publication August 9, 2011.
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understand how clotting is regulated depending on the
density and distribution of the activator.
The coagulation system’s response to TF exposure is
known to depend in a trigger-like manner on either surface
TF density (10) or concentration (11). Density and TF distri-
bution appear to be critical. Clotting is initiated in plasma
only when the TF-exposed region exceeds a threshold size
(12). Curiously, clotting was also reported to depend on
the shape of the activating region: although a narrow rectan-
gular or star-shaped patch of TF does not activate plasma
clotting, a circle with the same area and TF density does
(13). Furthermore, our previous report (14) showed that con-
fluent cell monolayers with varying TF expression levels
activate coagulation differently. Interestingly, in the same
experimental system, no difference was observed for clot-
ting in normal plasma activated by fibroblast monolayers
with cell densities of 2 or 1000 cells/mm2 (6).
The molecular mechanisms that control the surface TF
density threshold and are responsible for recognition of
the activating patch size and/or shape remain unclear.
Certain mathematical models suggest that positive feedback
loops (activation of the top factors in the cascade by the
enzymes that occupy the bottom positions) might be respon-
sible for providing a simple cascade system with a trigger-
like dependence on activator density and patch size
(12,15–17). The critical role of factor V in feedback activa-
tion by thrombin for triggering homogeneous coagulation
was recently demonstrated experimentally (11).
To investigate how coagulation depends on surface TF
density and distribution, and identify the mechanisms ofdoi: 10.1016/j.bpj.2011.08.034
Feedback Loops Supply Sensitivity to Local Tissue Factor Density 1817this regulation, we used two different patterns of clotting
activation: TF-expressing cells and uniformly distributed
surface-immobilized TF (Fig. 1). For both experimental
designs, the average surface TF density varied by two orders
of magnitude. Experiments in normal plasma and fV-, fVII-,
and fVIII-deficient plasma, using a reaction-diffusion
in vitro experimental model, were performed with computer
simulations that employed a detailed three-dimensional
(3D) mathematical model of blood coagulation. Clot forma-
tion was controlled by local, small-scale TF density; for
example, highly procoagulant fibroblasts rapidly activated
clotting independently of the average surface TF density.
This sensitivity to TF density was controlled by two positive
feedback loops: activation of the TF-VII complex by fXa,
and activation of fV by thrombin.MATERIALS AND METHODS
Proteins
The following materials were purchased from the sources shown in
parentheses: human fVa, fV, fIXa, thrombin, and RVV-Vactivator (Haema-
tologic Technologies, Essex Junction, VT); recombinant factor VIIa and
NovoSeven (Novo Nordisk, Copenhagen, Denmark); human fVIII (Hemo-
phil M, Baxter Russia, Moscow, Russia); EDTA (Helicon, Moscow,
Russia); PPACK (Calbiochem, Darmstadt, Germany); fXa-specific chro-
mogenic substrate S2765 (Chromogenix, Milano, Italy); and human
prothrombin and fXa (Enzyme Research Laboratories, South Bend, IN).
The thrombin-specific chromogenic substrate, Gly-Pro-Arg-NA, was syn-
thesized in the Russian Cardiology Research and Production Complex
of Ministry of Health Care and Social Development (Moscow, Russia).
The specific fXIIa inhibitor, corn trypsin inhibitor (CTI), was prepared
from corn seeds as described previously (18). Phospholipid (PL) vesicles
were prepared by extrusion from phosphatidylcholine and phos-
phatidylserine (Avanti, Alabaster, AL) at a molar ratio of 7:3, as described
previously (19).FIGURE 1 Blood clotting activation on TF-expressing surfaces in
a vessel (in vivo) and in a reaction-diffusion experimental model (in vitro).
Under normal conditions, TF is expressed by subendothelial cells only. In
many pathological conditions, such as inflammation and cancer, TF can
also appear on the surface of blood cells and endothelial cells, either iso-
lated or in monolayers. TF density varies over a wide range. By analogy,
coagulation in the in vitro model system used herein was activated by films
with either uniformly distributed TF or TF-bearing cells. In both cases, the
average surface TF density varied over two orders of magnitude. Spatial
clot growth was recorded by means of light scattering. Initiation times,
clot growth rates, and clot sizes after 40 min were determined as shown.Plasma preparation
Normal plasma was prepared from the whole blood of healthy volunteers
and collected with the approval of the ethics committees of the Center
for Theoretical Problems of Physicochemical Pharmacology and the
National Research Center for Hematology. Blood was drawn into 3.8%
sodium citrate (pH 5.5) at a 9:1 blood/anticoagulant volume ratio and
supplemented with CTI at a 0.2 mg/ml final concentration to inhibit contact
activation. A routine protocol was used to obtain plasma with stable
and reproducible procoagulant lipid content. Blood was centrifuged at
1600  g for 15 min, and the supernatant was collected and centrifuged
again at 10,000  g for 5 min to obtain platelet-free plasma, which was
lactate-treated to stabilize the pH at 7.2–7.4 (6). fV-, fVII-, and fVIII-
deficient plasma (George King Bio-Medical, Overland Park, KS) was
thawed in a 37C water bath, supplemented with CTI, incubated at room
temperature for 4 h to inhibit the enzymes formed from cold-promoted
activation (14), and then processed as normal plasma.Preparation of the fibroblast films
A human fetal lung fibroblast line was obtained from the Ivanovskii
Research Institute of Virology (Moscow, Russia). The films were prepared
as described previously (6). A detailed description is available in the
Supporting Material.TF immobilization on the films
TF was biotinylated and immobilized on films with covalently bound
streptavidin (SAM2 Biotin Capture Membrane, Promega, Madison, WI).
A detailed description is available in the Supporting Material.Assembly of intrinsic tenase on films
with immobilized TF or fibroblasts
The ability of the TF-bearing films to provide binding sites for the intrinsic
tenase was evaluated based on their acceleration of fX activation. A mixture
with TF-bearing films, fIXa, fVIIIa (prepared immediately), and fX was
used. We evaluated fXa activity using the rate of S2765 hydrolysis as
measured by absorbance at 405 nm using a Thermomax microplate reader
(Molecular Devices, Sunnyvale, CA). A detailed description is available in
the Supporting Material.Assembly of prothrombinase on films
with immobilized TF or fibroblasts
To evaluate prothrombinase-supporting activity, we prepared a mixture of
TF-bearing films, fXa, RVV-Vactivated fV, and prothrombin. We evaluated
thrombin activity using the rate of Gly-Pro-Arg-NA hydrolysis as measured
with a Thermomax reader. A detailed description is available in the
Supporting Material.Spatial clot growth in the reaction-diffusion
system and image processing
We studied spatial fibrin clot formation using a light-scattering videomicro-
scopy system, and determined the parameters of spatial clot formation from
the experimental image series as described previously (6). The initiation
time for clot formation was defined as the time interval required for the
mean light-scattering intensity near the activator to reach the half-
maximum value for a clot activated by the film with the maximum TF
density. For each frame, the clot size was determined as the distance
between the activation film and the edge of the clot (the clot edge wasBiophysical Journal 101(8) 1816–1824
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maximum value for a clot activated by the film with the maximum TF
density). The rate of clot growth was derived from the clot size versus
time curve as a mean rate within the range of 10–40 min after the onset
of clotting (Fig. 1). The clot size after 40 min from the beginning of clot
activation was also registered. A detailed description is available in the
Supporting Material.Computer simulations
We performed computer simulations of blood clotting using a detailed
mechanism-driven mathematical clotting model in a 3D reaction-diffusion
system. The model was based on another model that was developed earlier
by our group (11,20,21). The reaction kinetics was described by a set of
partial differential equations. All model constants were taken from the ex-
perimental reports without adjustment. The 3D equation system was solved
using finite element method software (COMSOL Multiphysics, Comsol,
Burlington, MA). The model was biphasic, i.e., reactions took place both
at the surface with TF and in the plasma volume. The activator was located
on the bottom surface as uniformly distributed TF or TF spots (see Fig. S1,
A and B, in the Supporting Material). Clotting parameters were calculated
from fibrin concentrations based on the assumption that the fibrin concen-
tration is proportional to light scattering (14), as an average fibrin concen-
tration across the surface corresponds better to the spatial experiments. The
average fibrin concentration was calculated as the mean concentration at
some distance from the surface and treated as a light-scattering profile. A
detailed description of the model is provided in Fig. S1.RESULTS
Clot formation as a function of surface TF density
To investigate clotting regulation by TF density, we acti-
vated coagulation in plasma by TFs that were uniformly im-
mobilized on films at densities from 0.7 to 107 pmol/m2.
Fig. 2 A shows pictures that are typical of clots formed
upon activation with 96 and 6 pmol/m2 TF density at 5
and 50 min from the beginning of the experiment. A
comparison of light-scattering profiles showed that clot
structure depended on TF density. The clots growing from
the films with high TF densities (30–107 pmol/m2) had steep
fronts (Fig. 2 B, top, and Fig. S6) and propagated into
plasma without changing shape. Light-scattering intensityIm
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Biophysical Journal 101(8) 1816–1824was proportional to fibrin concentration (14), and thus one
can conclude that fibrin density remained constant within
these clots. With a decrease in TF density, light-scattering
profiles became diffusive; there was neither a steep front
nor a plateau (Fig. 2 B, bottom).
The parameters for clot growth were determined for the
entire range of TF densities. We found that the initiation
time dramatically depended on TF density and steadily
decreased with an increase in TF density (Fig. 3 A). For TF
densities below 1.4 pmol/m2, clots did not form for at least
2 h. Differences in initiation time values were up to
30-fold within the experimental range of TF densities. The
clot growth rate decreased with a decrease in TF density
(Fig. 3 B). Clot growth rate decreased ~2-fold for a TF
density decrease from 107 to 5 pmol/m2. An initiation time
increase with a clot growth rate decrease led to a dramatic
clot-size dependence on activator density (Fig. 3 C).
Thus, throughout the experiment, large fibrin clots were
formed on the films with high TF densities, but no clot
formation was detected for those with the smallest TF densi-
ties. With lower TF densities, delayed clot formation and
smaller clot sizes were observed. Thus, clotting is highly
sensitive to changes in the density of TF that is uniformly
distributed on a surface. We also sought to determine
whether the behavior of the clotting system changes when
the same quantity of TF is redistributed nonuniformly on
a surface as localized spots.A single fibroblast is sufficient to activate clotting
We investigated how the density of TF-expressing cells
influences blood-clotting activation. Films with cell densi-
ties ranging from 10 to 1000 cells/mm2 were used. This
range of cell densities included both dense fibroblast mono-
layers and sparsely distributed cells (Fig. S8). Using films
with extremely low cell densities, we can study how single
cells activate clotting. The maximal distance between adja-
cent cells was 300 mm, and cell size was 71  11 mm. Thus,
clots were formed by individual cells.Clot size FIGURE 2 Effect of uniformly immobilized TF on
fibrin clot growth in normal plasma depends on the
TF density. Typical experimental results for platelet-
free plasma coagulation activated by TF at 96 and
6 pmol/m2 are shown. (A) Images of fibrin clots
for different TF densities as registered by light scat-
tering are shown. Clotting was performed in thin
layers of plasma from healthy donors. The activating
surface was located on the vertical wall of the experi-
mental chamber and is shown as a vertical stripe at
the left end of each image. During the experiment
(2 h), large fibrin clots were formed on the films
with high TF densities, but no clot formation was
detected with the lowest TF density. For lower TF
ing profiles of clot growth (note the different scales). Each curve (profile)
urve corresponds to 5 min after recalcification, and the subsequent curves
rves shift upward (implying that the clot becomes denser) and to the right
f time. The plots were obtained using the series of profiles shown in panel B.
FIGURE 3 Clotting activation by fibroblasts was
independent of their density, whereas clot formation
by uniformly immobilized activators was sensitive
to TF density. Initiation time (A), clot growth rate
(B), and clot size after 40 min (C) are plotted as func-
tions of average TF density for uniformly distributed
TF (solid gray circles) and TF-expressing cells (solid
dark gray circles). Normal plasma from 23 donors
was used. For data approximation, the mathematical
functions used were a second-order exponential (A),
hyperbolic (B), and hyperbolic plus linear (C). Appro-
ximation curves are supplemented with the corre-
sponding mean5 SE.
Feedback Loops Supply Sensitivity to Local Tissue Factor Density 1819Average TF densities for fibroblast-containing films
ranged by two orders ofmagnitude, from 0.5 to 135 pmol/m2,
and overlapped with the corresponding range of TF densi-
ties for uniformly distributed TF.
In contrast to experiments with uniformly distributed TF,
clot formation activated with TF-expressing cells mostly did
not depend on the average TF density throughout the entire
TF density range. Initiation times and clot growth rates had
only a weak dependence on average TF density. Initiation
time increased only twofold when the average TF density
was decreased by two orders of magnitude (Fig. 3 A). A
slight decrease in clot growth rate was observed, although
it was smaller than in experiments with TFs that were
uniformly immobilized on a surface (Fig. 3 B). Clots prop-
agated from films with cells, and after 40 min, the clot size
was >700 mm in all experiments (Fig. 3 C).
We controlled the activity of the TF-VIIa complex on
films with both immobilized thromboplastin and fibroblasts
using a functional assay. This result suggests that the exper-
imentally observed differences in clot formation parameters
were not caused by differences in the TF source but by the
TF distribution. Thus, the process of clot activation using
the same TF quantities dramatically depends on TF presen-
tation on the surface. Clotting is initiated quickly, and the
clot grows rapidly upon activation with fibroblasts through-
out the entire range of TF densities.Model design
Thus far, we have discussed two effects: 1), the trigger-like
dependence of blood plasma clotting initiation time on
the density of the TF uniformly distributed over a surface;
and 2), the independence of initiation time on average TF
density over the same density range for fibroblasts. To test
whether these results can be explained by differences in
TF distribution only, and propose hypotheses that explain
such results, we used a mathematical model. We performed
computer simulations of blood clotting using a mathe-
matical clotting model in a reaction-diffusion system (see
Supporting Material for details). The principal equation
scheme is shown in Fig. 4 A. The reaction kinetics was
described by a set of differential equations.A simple cascade of enzymatic reactions without
feedback loops does not sense surface activator
distribution
We wanted to ascertain whether TF distribution on the sur-
face is necessary and sufficient for experiments with both
uniformly distributed TFs and cells. Thus, we calculated the
initiation times using a model and the same range of average
TF densities that was used in the experiments. Two con-
ditions were simulated: uniformly distributed surface-bound
TFs and uniformly distributed rectangular spots of bound
TFs with a size and density similar to those of fibroblasts.
In both cases, average TF density was varied over a wide
range. TF density at the spots was not changed, but distance
between the spots was altered. Local TF sensitivity was not
observed in a simple cascade system without feedback
loops because, in that case, fibrin quantity was proportional
to the average density of the activator (Fig. 4 B, open circles).The system becomes sensitive to local TF density
when positive feedback loops are introduced
In contrast, there was a difference between two types of
activation in the model with positive feedback loops
(Fig. 4 B, solid circles). Initiation time plots over average
TF densities qualitatively corresponded with the experi-
mental data in both cases (Fig. 4 C). Initiation time was
mostly independent of average TF density for the modeled
spot-activated clotting with high TF density. In contrast,
TF uniformly immobilized on the surface dramatically
enhanced the TF-density dependence of the clotting process.
Initiation times at low average TF densities were substan-
tially different between activation by uniformly distributed
TFs and TF-bearing spots. Thus, the same TF quantities
yielded the formation of different fibrin quantities depend-
ing on TF distribution at the surface. To study the roles of
individual feedback loops, the rates for fV, fVII, fVIII,
and fXI activation were each set to zero (Fig. 4 D). Only
two positive feedback loops, for fV activation by thrombin
and fVII activation by fXa, led to a difference in the two
types of TF localization (Fig. S3). This result suggests
that the absence of these reactions led to a loss of sensitivityBiophysical Journal 101(8) 1816–1824
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FIGURE 4 fV activation by thrombin and fVII acti-
vation by fXa are essential for clotting system recog-
nition of the local TF concentration. A detailed
mechanism-driven mathematical model was used.
(A) General equations (F, factor; A, activator; I, inhib-
itor; t, time; x, spatial coordinate). (B) The ratio of
total fibrin generated upon clotting activation by
spotted TF to that generated upon stimulation with
the same quantity of uniformly distributed TF in the
models with and without feedback loops. (C) Depen-
dence of the initiation time on the average surface
TF density. Clotting was activated by uniformly
distributed TF (gray lines) or by rectangular spots
(dark gray lines) with a high TF density (60  15 mm
size and 500 pmol/m2 TF density) in a 3D region.
To evaluate the role of feedback loops in clotting
sensitivity to TF distribution, we individually
switched off positive feedback loops for fV, fVII,
fVIII, and fXI activation by setting the rates of these
reactions to zero in our computer simulations (D).
The average TF density for this series of simulations
was 12.5 pmol/m2.
1820 Balandina et al.to the surface distribution of the activator. For the activation
of fVIII and fXI by thrombin, the influence was minimal;
these feedback loops only slightly increased the difference
between types of TF localization. A severalfold difference
in the binding ability of uniformly immobilized TF and
TF spots did not affect the phenomena (Fig. S2).Roles of factors V and VII in feedback activation:
acceleration of clotting initiation
We calculated the contributions from fVand fVII activation
using the model system to clarify why fVand fVII activation
is essential for the clotting system’s sensitivity to surface TF
distribution. We simulated two cases: homogenous clotting
activation and activation at a surface with uniformly distrib-Homogeneous TF
destribution
TF uniformly immobilized 
on surface
Surface TF d
tendency to hom
tion of clotting disappeared, suggesting that fVII activation by fXa is importa
additional fVIIa activated fXa and compensated for its diffusion.
Biophysical Journal 101(8) 1816–1824uted TFs (Fig. 5, left andmiddle). The fVII activation by fXa
was important for clotting initiation only when the activator
was localized to the surface. What changes in the system
during translocation of TF from the entire volume to the
surface? We suggest that, in the latter case, diffusion of all
the clotting system components is essential. When we
analyzed the contribution from diffusion of individual
components, we found that fXa diffusion was the only
essential activity (data not shown). When the fXa diffusion
coefficient was increased, the initiation time curves for the
system, with and without fVII activation, were the same
as for homogeneous TF activation (Fig. 5 right).
To summarize, the mathematical model showed that the
positive feedback loops for fV and fVII activation were
necessary and likely sufficient to supply clotting activationistribution at 
ogeneous model
FIGURE 5 Spatial TF distribution defines the role
of positive feedback for fVII activation in clotting.
To compare the roles of fV and fVII feedback loops,
initiation time dependencies on TF concentration and
density were calculated for normal plasma and
plasma without either fVII or fV activation. A
detailed, mechanism-driven mathematical model
was used. (Left) When TF was distributed homoge-
neously, only the fV activation feedback loop was
essential for clotting. (Middle) When immobilized
TF was uniformly distributed over the surface in
3D computer simulations, the feedback loops for
both fV and fVII activation influenced the initiation
time. (Right) TF was uniformly immobilized at the
surface, and the fXa diffusion coefficient was
increased by 104 to mimic homogeneous TF distribu-
tion. The role of positive feedback in the fVII activa-
nt for the clotting process only when fXa is removed by diffusion; thus,
Feedback Loops Supply Sensitivity to Local Tissue Factor Density 1821sensitivity to high TF density at individual spots and the
same quantity of TF uniformly distributed on the surface.Feedback loops for activation of factors V and VII
supply clotting system sensitivity to TF
distribution at the surface
To test the prediction that fV and fVII activation feedback
loops render blood coagulation sensitive to the spatial distri-
bution of TF, we performed experiments using fV-, fVII-,
and fVIII-deficient plasma (Fig. S9). To shorten initiation
times, fVII- and fV-deficient plasma was supplemented
with small quantities of fVIIa and fVa, respectively. As a
control, a mixture of fV- and fVII-deficient plasma at a
1:1 volume ratio was used. In agreement with the computer
simulations, the difference in initiation times for activation
by immobilized TF and cells almost disappeared in the
fV- and fVII-deficient plasma. For fVIII-deficient plasma,
the difference remained the same as in normal plasma.
This result confirms the model prediction that positive feed-
back loops for fV and fVII activation are essential for
clotting system sensitivity to surface TF distribution and
its local density (Fig. 6).
In contrast to normal plasma, the clot growth rates in fV-
and fVII-deficient plasma were similar for clotting activa-
tion with either uniformly distributed or spotted TF, and
the clot sizes 40 min after the beginning of the experiment
were also similar (Fig. S10). Without fVIII, however, differ-
ences in clot growth rates and clot sizes for these two casesBA
FIGURE 6 Positive feedback loops for fVand fVII activation render clot-
ting sensitive to surface TF distribution. To validate the mathematical
model prediction that the clotting system can recognize local TF concentra-
tion only after fV and fVII activation, we performed experiments with fV-,
fVII-, and fVIII-deficient plasma. The mathematical model (A) and exper-
imental data (B) are shown. The average TF density was 6.25 pmol/m2 for
the mathematical model and 8 pmol/m2 for the experiments. Plots show the
initiation times for the control plasma and the fV-, fVII-, and fVIII-deficient
plasmas. Immobilized TF and TF-bearing cells were used to activate clot-
ting. For the control plasma, a mixture of fV- and fVII-deficient plasma
at a 1:1 volume ratio was used. To enhance clot activation, fV-deficient
plasma (<1%) was supplemented with fVa (0.1% of the normal experi-
mental fV concentration and 1% for the model), and fVII-deficient plasma
was supplemented with <1% VIIa (1% of the normal fVII concentration).
Control and fVIII-deficient plasmas were sensitive to TF distribution in the
clotting process, whereas fV- and fVII-deficient plasma showed only small
differences between activation by uniform immobilized TFs and fibroblasts.
Experimental data are shown with the corresponding SD (n ¼ 3O5).of surface TF distribution increased, even compared with
normal plasma. This result indicates that the feedback loops
for fV activation by thrombin and TF-fVII complex activa-
tion by fXa are essential for fast clot growth with a concen-
trated activator and slow clot growth with uniformly
distributed surface TFs. Clots growing in fV- and fVIII-
deficient plasma had more diffuse profiles than normal
and fVII-deficient plasma, and did not have a distinct
boundary between the fibrin clot and liquid plasma, in con-
trast to the control and fVII-deficient plasma (Fig. S11).
Thus, the feedback loops for fV and fVIII activation by
thrombin abruptly switched between fibrin clots and liquid
plasma.Effect of plasma and cell surface lipids
on the ability of the coagulation system
to sense local TF density
To ensure that the difference between fibroblasts and immo-
bilized TF was not caused by factors other than the TF
distribution (for example, a difference in tenase and pro-
thrombinase activity), we performed control experiments
to evaluate their procoagulant activity. The ability of the
films to support prothrombinase was both low and identical
(Fig. 7 A). Immobilized TF had higher procoagulant activity
compared with intrinsic tenase in fibroblasts (Fig. 7 B).
However, the effects were also small (films with the maxi-
mum density, at 4 mm2/60 ml, were similar to PL at
200 nM). Thus, a higher procoagulant activity in immobi-
lized TF cannot support the enhanced fibroblast clotting
observed in this study.
To test whether the phenomena observed in this study
depend on plasma lipid concentration, and to exclude the
possibility of artifacts from insufficient surface binding for
factors such as Xa, Va, and VIIa, we performed control
experiments in plasma supplemented with PL at 10 mM.
These data, presented in Fig. 7 C, show that PLs shortened
the clotting initiation times by ~2-fold in all cases but had no
effect on the phenomenon itself; fibroblast clotting was still
activated more rapidly than uniformly immobilized TF of
the same surface density by an order of magnitude. As an
additional control, we added both fVIIa (10 nM) and PL
(10 mM) to normal plasma activated with either fibroblasts
or immobilized TF, and the difference between the activa-
tors was greatly decreased (Fig. 7 C). These data confirm
that it is the positive feedback loops, not lipid (un)avail-
ability, that determine coagulation sensitivity to local TF
density independently of other conditions used in this study.DISCUSSION
The purpose of the study was to investigate the dependence
of spatial clot formation on surface TF density and distribu-
tion. The principal results were as follows: 1), the clotting
system is sensitive to the density of uniformly distributedBiophysical Journal 101(8) 1816–1824
A B C FIGURE 7 Effect of plasma and cell surface
lipids on the sensitivity to local TF density during
coagulation. (A) Thrombin production by pro-
thrombinase assembled on PL, films with fibro-
blasts, or films with immobilized TFs. Shown are
the mean 5 SD, n ¼ 8O16. (B) fXa production
by intrinsic tenase assembled on either PL, films
with fibroblasts, or films with immobilized TFs.
Shown are the means5 SD, n ¼ 4O6. (C) Effect
of PL (0 and 10 mM) and fVIIa (0 and 10 nM) on
the clotting initiation time. Clot formation was initiated by films with fibroblasts or immobilized TFs, both with an average surface density of 8 pmol/m2.
Control films are films without TFs. Shown are the means5 SD, n¼ 3O7. Asterisks show a significant difference, and double asterisks show a lack thereof,
as calculated using an unpaired, two-sample t-test at p ¼ 0.05.
1822 Balandina et al.TF, as clotting initiation time increased with a decrease in
TF density; 2), in contrast, immobilized fibroblast cells
always activated clotting rapidly, independently of their
monolayer density; and 3), the distinction in the clotting
response to surface TF distribution was determined by two
positive feedback loops, TF-fVII complex activation by
fXa and fV activation by thrombin.
These results confirm the concept that the blood clotting
system can, in a way, recognize patterns (13). For our exper-
iments, it recognized regions with high local TF density and
rapidly generated a fibrin clot proximal to these spots. When
the same TF quantity was uniformly distributed across
a larger surface, the clotting system was activated slowly
and clots did not form. When the activator was a high-
density TF spot, the clots always grew rapidly and did not
depend on the average nonlocal TF density.
Previous theoretical studies (16,22–24) predicted that in
enzyme cascades with positive feedback loops, activation
thresholds and sensitivities to local concentration and sur-
face density can arise. A previous experimental study (13)
demonstrated that clotting can depend not only on the area
of a TF-containing spot but also on its shape. The principal
new results from our study are identification of specific
coagulation factors and feedback loops that are important
for recognizing regions with high local TF density. This
ability is controlled by two positive feedback loops: fVacti-
vation by thrombin and TF-fVII complex activation by fXa.
Our simulations suggest that all of the thresholds for coag-
ulation (i.e., thresholds for TF density, TF-bearing spot size,
and blood flow rate (21)) in this reaction-diffusion system
are determined by these two feedback loops. Two addi-
tional positive feedback loops, fVIII and fXI activation by
thrombin, do not affect clotting system sensitivity to TF
distribution.
Our conclusions from this study are based on a compar-
ison of two types of activators: TF-expressing cells and
uniformly distributed TF. Although the use of native cells
renders the experimental conditions more physiological,
and we quantitatively determined TF density in all cases,
one cannot rule out differences between cells and noncell
TF in addition to surface distribution. We performed the
following additional control experiments to test this possi-
bility: First, we determined the ability of the cells and non-Biophysical Journal 101(8) 1816–1824cell TF to support intrinsic tenase and prothrombinase
activity. Second, we performed 3D computer simulations
of clotting activation by uniform and spotted TF. Finally,
we tested the effects of Kd differences between cells and
noncell TFs. These results support the conclusion that the
principal cause of the difference between cells and noncell
TF activation is a difference in surface distribution. Contri-
butions from additional factors were detectable and likely
do not affect our conclusions.
Feedback from fV activation aids the clotting system in
forming a clear boundary between fibrin clots and liquid
plasma. Clots with a wide range of unstable states, between
solid fibrin polymer and liquid plasma, were formed in fV-
deficient plasma. In a previous study (11), we showed that
for homogeneous clotting activation, this reaction functions
similarly: fV activation feedback minimizes the temporal
and parametric (TF concentration) intervals of clot insta-
bility. Patients with an fV deficiency were previously re-
ported to experience thromboembolisms (25). That report
may be consistent with our results, which show a role for
fV-activation feedback. One can speculate that blood flow
detaches unstable clot portions and causes the embolism.
The role of fVII activation by fXa was previously unclear.
Its participation in activation threshold formation has been
suggested (22), but it has not been observed in a mecha-
nism-driven clotting model for a homogeneous system
(11). FVII activation has also been suggested as a trigger
for kinetic changes in coagulation during blood flow along
the activation region (21), as fXa is removed from the gener-
ation region by flow. Here, we propose a novel (to our
knowledge) role for this reaction in the regulation of spatial
clotting with low surface TF density (Fig. 8). FXa removal
through diffusion is essential in the clotting system, because
it is slowly generated. The special role of the fVII activation
feedback loop is to enhance the rate of clot growth at spots
with high local TF density. Using a mathematical model, we
demonstrated that this reaction is only essential in the reac-
tion-diffusion system. The component that is sensitive to
spatial heterogeneity is fXa. The influence of the feedback
increases as the contribution from diffusion increases.
Thus, fXa accumulation near a TF-bearing surface enhances
the influence of fVII feedback activation on the clotting
system compared with uniform surface TF distribution.
FIGURE 8 Positive feedback loops supply sensitivity to surface TF
distribution during coagulation. (Left) When clotting is activated by cells
with a high surface TF density, fX activation is more important than the
removal of fXa due to diffusion and inhibition. This result is reinforced
by the feedback loop for fVII activation, and the clot rapidly forms near
the cells and propagates from them. (Right) In contrast, if the same quantity
of TF is distributed uniformly across the surface, then fXa removal and
inactivation predominate, and clot formation is prevented.
Feedback Loops Supply Sensitivity to Local Tissue Factor Density 1823When the same quantity of fXa was uniformly distributed
throughout the volume, fV and fVII activation played the
same role in clotting as it did in homogeneous distribution.
The role of fV activation was retained, whereas the role of
fVII activation disappeared. Thus, our study shows that
fVII feedback activation is not important at a high TF
density, but is critical at low TF density. Previous studies
showed that flow can enhance the influence of this feedback
loop even at high TF density (21), whereas this feedback
loop had no effect on homogeneous clotting activation
(11). These three findings parallel one another, i.e., they indi-
cate that fVII feedback during coagulation forms additional
thresholds under unfavorable, spatially nonuniform activa-
tion conditions (when TF is low or rapidly removed by flow).
These results supplement earlier work on the function of
the clot system. We can assume that the complicated reac-
tion system for clotting can be decomposed into functional
modules with unique roles (11). Currently identified roles
include fibrin polymerization, activation triggered by the
positive feedback loops for fV and fVII activation, spatial
propagation by positive feedback loops for fVIII and fXI
activation, and termination of spatial propagation by a nega-
tive feedback loop in the protein C pathway (20).
The practical significance of the results obtained in this
study is the potential for selectively regulating various pro-
cesses and properties in the coagulation response. When
clotting is activated in vivo, the activation signal (i.e., TF
density and distribution, and activating region size) can
vary greatly. TF is expressed by endothelial cells and mono-
cytes upon the action of toxins, cytokines, lipids, TFN-6,
immune complexes, and other signals (26–30). Thus, at a
low density of uniformly distributed activators, clotting
begins after tens and even hundreds of minutes. This amount
of time is sufficient for the removal of activated enzymes by
blood flow and the blood clearance system. Thus, clots are
not formed at all when the cells begin expressing TF at
low densities, even on a large region. In contrast, a single
cell with high TF expression can effectively cause clot
formation. Information regarding each reaction’s role duringclotting formation may aid in specifically influencing the
system during pathological conditions. For example, inhibi-
tion or stimulation of fVand fVII activation canmodulate the
clotting system’s sensitivity to activator distribution.SUPPORTING MATERIAL
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